Eco-robotics for nature-based solutions.
Location: Switzerland, Bern
Employees: 51-200
Total raised: $172.38K
Founded date: 2022
Investors 1
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.07.2023 | - | $172.38K | Venture Ki... |
Mentions in press and media 8
| Date | Title | Description |
| 14.08.2023 | Brainforest inaugurates venture program with five projects | |
| 31.07.2023 | CHF150k to make wetland restoration lucrative | |
| 31.07.2023 | Venture Kick invests CHF 150,000 in Inverto to make wetland restoration profitable | Wetlands and mangrove forests are not only some of the earth’s most critical ecosystems, but are carbon sequestration superstars, capable of sequestering 4 to 10 times the CO2 of terrestrial forests at rates 400% faster. This makes them par... |
| 29.06.2023 | Digitalswitzerland powers biodiversity | |
| 24.05.2023 | The SEIF Tech for Impact Awards nears the finale | |
| 23.05.2023 | ESA BIC Switzerland promotes five startups with Space connections | |
| 23.01.2023 | CH 40,000 for a novel drug delivery system to prevent stenosis, a patented biomaterial platform revolutionizing the way drugs can be administered to patients, and mangrove restoration to speed-up carb... | ArtemiX Biotech: a novel drug delivery system to prevent stenosis Chronic kidney disease (CKD) is a serious, life-threatening, and growing health problem affecting millions of patients worldwide. Patients with CKD have significantly reduced... |
| 26.10.2022 | Startups developing a novel drug delivery system, the next generation of AI assistants on mobile devices, mangrove planting as a service, AI tractor operator, and PET using the novel alpha-synuclein i... | ArtemiX Biotech: a novel drug delivery system to prevent stenosis Arteriovenous fistula (AVF) or arteriovenous graft (AVG) are routinely conducted to enable hemodialysis for patients with kidney failure. Around 100,000 AVFs and 60,000 AVGs ... |